Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Consults On ‘Essential Principles’ Ahead Of New Rules For Devices, IVDs

Executive Summary

India’s draft guidance describes fundamental design and manufacturing requirements that, when met, indicate a medical device or IVD is safe and performs to its specification.

You may also be interested in...



Global Medtech Guidance Tracker: July 2017

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twelve new guidance documents were posted to the tracker in July.

Indian Medtech Finds Errors In New Draft List Classifying Devices, IVDs

India’s industry association claims that some of the products on the regulator’s new draft list classifying over 700 medical devices and IVDs have been categorized incorrectly. The list is expected to be finalized at least three months before new medical device rules come into effect in January 2018.

EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions

After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT105199

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel